(Q80068250)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

David S Pearlman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Janet van Adelsberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

George Philip

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Stephen A Tilles

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

William Busse

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Leslie Hendeles

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

S Balachandra Dass

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Theodore F Reiss

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

98-104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

Exercise-induced bronchoconstriction

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Inflammatory basis of exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Control of airway function during and after exercise in asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Urinary leukotriene E after exercise challenge in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Single-dose agents in the prevention of exercise-induced asthma: a descriptive review

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Management of exercise-induced bronchospasm in children: the role of leukotriene antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Long-acting beta 2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

A randomized controlled trial of intravenous montelukast in acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Exercise-induced asthma: a practical guide to definitions, diagnosis, prevalence, and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Nedocromil sodium vs. sodium cromoglycate for preventing exercise-induced bronchoconstriction in asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Pathogenetic mechanisms of exercise-induced asthma and the refractory period.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Demonstration by placebo response in asthma by means of exercise testing.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Past, present and future--beta2-adrenoceptor agonists in asthma management

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Choices of therapy for exercise-induced asthma in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961377-4

7 January 2021

10.1016/S1081-1206(10)61377-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892789%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference